Location: United States, Massachusetts, Boston
Investors 2
| Date | Name | Website |
| 14.07.2022 | Robin Hood... | robinhoodv... |
| 11.08.2021 | Allied Min... | alliedmind... |
Mentions in press and media 3
| Date | Title | Description |
| 09.11.2021 | OcuTerra snags $35M for phase 2 trial of eye drop with former Allergan CEO as chair | OcuTerra Therapeutics has been on a journey to rebrand and reboot its vision for getting an eye drop to market. Now, with ex-Allergan CEO Brent Saunders as chair, the biotech has $35 million to bankroll a phase 2 trial of its single asset. ... |
| 09.11.2021 | OcuTerra snags $35M for phase 2 trial of eye drop with former Allergan CEO as chair | OcuTerra Therapeutics has been on a journey to rebrand and reboot its vision for getting an eye drop to market. Now, with ex-Allergan CEO Brent Saunders as chair, the biotech has $35 million to bankroll a phase 2 trial of its single asset. ... |
| 09.11.2021 | OcuTerra Raises $35 Million Series B Financing | OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of care of “watch and wait” does not prevent or control the progression... |